Phibro Animal Health PAHC
NASDAQ PAHC
$39.81 +0.56 (+1.43%)
At close: Oct 22, 2026 · 4:00 PM EDT

Phibro Animal Health (PAHC) Receivables - Other (2013 - 2026)

Updated

Phibro Animal Health's Receivables - Other came in at $11.7 million for fiscal Q4 2026 (quarter ended Jun 30, 2026).

Analysis

Phibro Animal Health (PAHC) Receivables - Other (2013 - 2026) Analysis & Trends

  • The fiscal Q4 2026 figure represents the lowest quarterly Receivables - Other since fiscal Q3 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Phibro Animal Health 1.62 Bn 1.30 Bn 134.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.70 Mn
Mar 31, 2014 5.35 Mn
Jun 30, 2013 5.35 Mn
API Access

Phibro Animal Health Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=PAHC&period=max&api_key=YOUR_API_KEY